Comparison of a Torso-Based Derived 6-Lead Electrocardiogram (ECG) Device With Standard 12-Lead Electrocardiogram (ECG) in Healthy Volunteers
T-ECG
Comparison of 6-Lead Electrocardiogram (ECG) Device Data With Standard 12-Lead Electrocardiogram (ECG) Data in Individuals With Different Anthropometric Characteristics
1 other identifier
observational
24
1 country
1
Brief Summary
This study aims to compare electrocardiographic interval measurements obtained from a torso-placed six-lead electrocardiogram (ECG) device (torso-derived ECG; T-ECG) with those obtained from a standard 12-lead electrocardiogram (ECG) in healthy adult volunteers. The torso-derived device synthesizes limb-lead signals using electrodes positioned on the thorax, potentially allowing for faster and more practical ECG acquisition in emergency department settings, operating rooms, and prehospital environments. A total of 24 participants undergo both standard 12-lead ECG recording and torso-derived 6-lead ECG recording during the same study session. Heart rate (HR), PR interval, QRS duration, QT interval, and corrected QT (QTc) values are analyzed using Bland-Altman agreement analysis and correlation testing. The study also evaluates whether anthropometric characteristics-including body mass index (BMI)-influence the compatibility and agreement between the two measurement systems.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2024
CompletedFirst Submitted
Initial submission to the registry
November 26, 2025
CompletedFirst Posted
Study publicly available on registry
December 11, 2025
CompletedDecember 11, 2025
December 1, 2025
3 months
November 26, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
PR Interval Agreement Between Torso-Derived and Standard 12-Lead Electrocardiogram (ECG)
Mean difference in PR interval between torso-derived six-lead electrocardiogram (ECG) and standard 12-lead ECG recordings obtained during the same resting session. Single-session baseline ECG recording.
Single-session baseline ECG recording.
QRS Duration Agreement Between Torso-Derived and Standard 12-Lead Electrocardiogram (ECG)
Mean difference in QRS duration between torso-derived six-lead ECG and standard 12-lead ECG recordings obtained during the same resting session
Single-session baseline ECG recording.
QT Interval Agreement Between Torso-Derived and Standard 12-Lead Electrocardiogram (ECG)
Mean difference in QT interval between torso-derived six-lead ECG and standard 12-lead ECG recordings obtained during the same resting session.
Single-session baseline ECG recording
Heart Rate (HR) Agreement Between Torso-Derived and Standard 12-Lead Electrocardiogram (ECG)
Mean difference in heart rate (HR) between torso-derived six-lead ECG and standard 12-lead ECG recordings obtained during the same resting session.
Single-session baseline ECG recording.
Secondary Outcomes (1)
Agreement Between Torso-Derived 6-Lead Electrocardiogram (ECG) and Standard 12-Lead Electrocardiogram (ECG) Measurements
Single-session recording (baseline only)
Study Arms (1)
Healthy Volunteer ECG Group
Participants underwent standard 12-lead ECG and torso-based 6-lead ECG in a single session for comparative interval analysis.
Interventions
Non-invasive ECG measurement with torso electrode placement for comparison with standard 12-lead ECG.
Eligibility Criteria
The study population consists of healthy adult volunteers without known cardiovascular disease. All participants undergo both standard 12-lead electrocardiogram (ECG) recording and torso-derived 6-lead electrocardiogram (ECG) recording during a single study session. Participants are screened prior to inclusion to ensure the absence of baseline arrhythmia, ischemia, conduction delay, or structural heart disease.
You may qualify if:
- Age between 18 and 65 years
- No known cardiovascular disease
- No arrhythmia, conduction disorder, or ischemic electrocardiogram (ECG) changes at baseline
- Willingness to participate and ability to provide written informed consent
You may not qualify if:
- Known cardiac disease, including coronary artery disease (CAD), arrhythmia, heart failure, or valvular heart disease
- Pacemaker rhythm or baseline abnormal electrocardiogram (ECG) findings
- Thoracic deformity or prior thoracic surgery that prevents appropriate electrode placement
- Unwillingness to participate or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haydarpaşa Numune Training and Research Hospital - Emergency Medicine Department
Istanbul, 34668, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 26, 2025
First Posted
December 11, 2025
Study Start
December 6, 2023
Primary Completion
March 6, 2024
Study Completion
June 6, 2024
Last Updated
December 11, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the dataset includes only ECG recordings collected from healthy volunteers, and no identifiable patient-level information is stored or retained. Summary results may be shared in publication form, but raw individual-level data will not be publicly available.